NxStage Medical is a medical technology company that develops, manufactures and markets products and services for patients suffering from chronic or acute kidney failure. Co. conducts its operations in three segments: System One, in which Co. sells and rents the System One and PureFlow SL dialysate preparation equipment, and sells disposable products in the home and critical care markets; In-Center, in which Co. sells blood tubing sets and needles for hemodialysis, primarily for the treatment of end-stage renal disease patients at dialysis clinics, and needles for apheresis; and Services, which includes dialysis services provided to patients at Co.'s NxStage Kidney Care dialysis centers. We show 36 historical shares outstanding datapoints in our coverage of NXTM's shares outstanding history.
Understanding the changing numbers of NXTM shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like NXTM versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching NXTM by allowing them to research NXTM shares outstanding history
as well as any other stock in our coverage universe. |
Free NXTM Email Alerts:
Video: Shares Outstanding Importance
